Ava Raises $30 Million for Fertility Tracking Wristband
*By Christian Smith*
Ava, the medtech company that makes wristbands for women tracking their fertility, announced Wednesday that it raised $30 million in Series B funding, money its co-founder said would be used to continue the company's research.
"Women's health and women's health research has been underfunded for the last decade," Lea von Bidder, Ava's co-founder, said in an interview with Cheddar. "We want to do a lot of research in different fields of women's health ー be it pregnancy monitoring, be it contraception, be it menopause ーand hope to give women insights about their body and health."
Ava conducts its research through clinical trials with the University Hospital of Zurich, where the company was founded in 2014.
Its wearable tracker is like a Fitbit for fertility, monitoring nine physiological metrics including heart and breathing rates, skin temperature, and heat loss to determine a woman's fertility cycle. Von Bidder said the company's research shows that the device is 89 percent accurate in predicting the 5.3 fertile days in a woman's cycle. In addition to the tracker, Ava also offers an app, which tracks a woman's health during her pregnancy.
So far, 10,000 babies have been born to mothers using the Ava tracker, the company announced on Wednesday.
Ava's founder said they want to offer contraception and family-planning products, too, but the company doesn't have a time frame for these types of products.
"Ava at this point is not a contraceptive yet," von Bidden said. "We are working really hard on making that happen."
For the full interview, [click here](https://cheddar.com/videos/fertility-tracking-company-ava-raises-30-million-in-series-b-funding-round).
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Scott Trench, host of the BiggerPockets Money Podcast, explores how recent rate cuts, high borrowing costs, and mortgage rates are reshaping U.S. real estate.
A look into how disruption, AI, and global economic trends are transforming the modern supply chain with Jeremy Jansen, Head of Supply Chain at Wells Fargo.
Delta CSO Amelia DeLuca reveals at the Fast Co. Innovation Festival how tech, sustainable aviation fuel, and smart operations are revolutionizing air travel.
Chipmaker Nvidia will invest $100 billion in OpenAI as part of a partnership that will add at least 10 gigawatts of Nvidia AI data centers to ramp up the computing power for the owner of the artificial intelligence chatbot ChatGPT.
Two of the nation’s biggest real estate services companies are combining in a deal that will bring Century 21, Compass and several other major brokerage brands under the same umbrella.
Colin & Samir break down YouTube’s $100B payout to creators and explore why nearly a third of Gen Alpha want to be YouTubers — plus what that means for you.
